Bai Song S - OmicsDI

Show results for

Unknown (594)
Proteomics (15)
Metabolomics (3)
Transcriptomics (2)
Genomics (1)

Organisms

Homo sapiens (8)
Mus musculus (6)
Oryza sativa (1)
Arabidopsis thaliana (1)
Xenopus laevis (1)

Repository

pride (9)
iProX (5)
MetaboLights (3)
biostudies-arrayexpress (2)
EGA (1)
MassIVE (1)

Tissue

Cell culture (3)
Epithelial cell (3)
Colon (2)
Lung (1)
Macrophage (1)
Oocyte (1)
Pancreatic cancer cell (1)

Disease

Cervix carcinoma (1)
Colon cancer (1)
Lung cancer (1)
Pancreatic cancer (1)

Technology Type

Mass Spectrometry (9)
Bottom-up proteomics (4)
Mass spectrometry (3)
Shotgun proteomics (3)
Data-dependent acquisition (2)
Affinity purification coupled with mass spectrometry proteomics (1)
Top-down proteomics (1)

Instrument Platform

Liquid Chromatography MS - negative (2)
Liquid Chromatography MS - positive (2)
LTQ Orbitrap Velos (1)
Q Exactive (1)
Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2025 (7)
2023 (4)
2022 (2)
2019 (2)
2018 (2)
2014 (1)
2010 (1)
2024 (1)

CHEBI ID

CHEBI:136629 (1)
CHEBI:137157 (1)
CHEBI:138426 (1)
CHEBI:138517 (1)
CHEBI:138522 (1)
CHEBI:139131 (1)
CHEBI:141521 (1)
CHEBI:145278 (1)
CHEBI:15843 (1)
CHEBI:15971 (1)
CHEBI:16390 (1)
CHEBI:166698 (1)
CHEBI:166724 (1)
CHEBI:166727 (1)
CHEBI:16814 (1)
CHEBI:168628 (1)
CHEBI:169041 (1)
CHEBI:169554 (1)
CHEBI:170591 (1)
CHEBI:171768 (1)
CHEBI:171909 (1)
CHEBI:172591 (1)
CHEBI:172628 (1)
CHEBI:172648 (1)
CHEBI:172785 (1)
CHEBI:173299 (1)
CHEBI:174168 (1)
CHEBI:174173 (1)
CHEBI:174217 (1)
CHEBI:175697 (1)

Metabolite Name

1-Oleoylglycerophosphoserine (1)
16-Hydroxy hexadecanoic acid (1)
19-(3-methyl-butanoyloxy)-villanovane-13alpha,17-diol (1)
3a,7a,12b-Trihydroxy-5b-cholanoic acid (1)
3b,12a-Dihydroxy-5a-cholanoic acid (1)
3beta-(3-methyl-butanoyloxy)-villanovane-13alpha,17-diol (1)
7-Sulfocholic acid (1)
Acrimarine J (1)
Allolithocholic acid (1)
Americine (1)
Arachidonic acid (1)
Cavipetin A (1)
Chenodeoxycholic acid sulfate (1)
DG(14:0/19:0/0:0) (1)
Dehydroepiandrosterone sulfate (1)
Deoxycholic acid glycine conjugate (1)
Docosahexaenoic acid (1)
Dynorphin B (6-9) (1)
Epothilone B (1)
Gamma-Linolenic acid (1)
Ganoderic acid L (1)
Gentamicin (1)
Glyuranolide (1)
Hordatine A (1)
Lithocholic acid glycine conjugate (1)
Lithocholyltaurine (1)
LysoPE(0:0/22:1(13Z)) (1)
PA(14:1(9Z)/14:0) (1)
PC(16:0/5:0(COOH)) (1)
PE(18:0/20:5(5Z,8Z,11Z,14Z,17Z)) (1)

Study type

Transcription profiling by array (2)

Release Date

2025 (108)
2023 (103)
2022 (80)
2024 (68)
2021 (58)
2020 (49)
2019 (34)
2018 (22)
2026 (16)
2017 (15)
2016 (14)
2015 (10)
2014 (6)
2013 (6)
2012 (3)
2010 (2)
2011 (1)
2003 (1)

Lab affiliation

The First Affiliated Hospital, School of Medicine, Zhejiang University (2)
Biological Sciences, University of Southampton (1)
Changhai Hospital, Naval Medical University, Shanghai, 200433, China. (1)
Department of Biology, Henan University, Kaifeng 475001, The Peoples Republic of China. (1)
Department of Gastroenterology, The First Affiliated Hospital of Naval Medical University, Shanghai, 200433, China (1)
Harvard (1)
Harvard Medical School (1)
Thoracic Oncology Chemical Biology and Molecular Medicine Program Moffitt Cancer Center (1)

Previous page
1 / 62
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 62
Next page

Sort by:

Relevance

Page size

Unveiling Unusual Reactivity of SO<sub>2</sub> and Unusual Type of S-X Long Bonds.

Not available

S-EPMC12284863 | biostudies-literature

Comparative Genomic and Physiological Analysis against Clostridium scindens Reveals Eubacterium sp. c-25 as an Atypical Deoxycholic Acid Producer of the Human Gut Microbiota.

Not available

S-EPMC8623032 | biostudies-literature

DT-109 ameliorates nonalcoholic steatohepatitis in nonhuman primates

Nonalcoholic steatohepatitis (NASH) prevalence is rising with no pharmacotherapy approved. A major hurdle in NASH drug development is the poor translatability of preclinical studies to safe/effective clinical outcomes, and recent failures highlight a need to identify new targetable pathways. Dysr...

2023-04-13 | MTBLS5005 | MetaboLights

Breast cancer tumorigenicity is dependent on high expression levels of NAF-1 and the lability of its Fe-S clusters.

Not available

S-EPMC5047192 | biostudies-literature

Platelet Protease Activated Receptor 1 Is Involved in the Hemostatic Effect of 20(S)-Protopanaxadiol by Regulating Calcium Signaling.

Not available

S-EPMC7530267 | biostudies-literature

The Fe-S cluster-containing NEET proteins mitoNEET and NAF-1 as chemotherapeutic targets in breast cancer.

Not available

S-EPMC4378444 | biostudies-literature

Multi-omics analysis of β-catenin oncogenic networks

We used interaction and expression proteomic techniques in conjunction with RNA-Seq transcriptomic analysis to analyse how a β-catenin stabilizing mutation alters molecular networks in colorectal cancer cells. Integrated computational analyses of allowed us to identify significantly altered sub-netw...

ORGANISM(S): Homo sapiens (Human)

2018-05-18 | PXD006053 | Pride